ID

34545

Beschrijving

Imaging Control Study, 3D Echo, MR and RHC.; ODM derived from: https://clinicaltrials.gov/show/NCT02198456

Link

https://clinicaltrials.gov/show/NCT02198456

Trefwoorden

  1. 19-01-19 19-01-19 -
  2. 22-05-19 22-05-19 -
Houder van rechten

see on clinicaltrials.gov

Geüploaded op

19 januari 2019

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY-NC 3.0

Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Pulmonary Arterial Hypertension WHO Group I NCT02198456

Eligibility Pulmonary Arterial Hypertension WHO Group I NCT02198456

Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
age >17
Beschrijving

ID.1

Datatype

boolean

pulmonary arterial hypertension who group i who are going to start a therapy with prostanoid
Beschrijving

ID.2

Datatype

boolean

written informed consent
Beschrijving

ID.3

Datatype

boolean

prostanoid naive
Beschrijving

ID.4

Datatype

boolean

no change of the pulmonary arterial hypertension therapy within 3 weeks of inclusion into the study
Beschrijving

ID.5

Datatype

boolean

Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
pregnancy and lactation period
Beschrijving

ID.6

Datatype

boolean

women of childbearing potential who do not use an effective and secure method for birth control
Beschrijving

ID.7

Datatype

boolean

severe chronic kidney insufficiency (glomerular filtration rate <30), which will remain for more than 3 months
Beschrijving

ID.8

Datatype

boolean

liver insufficiency child c
Beschrijving

ID.9

Datatype

boolean

life expectancy shorter than the course of the study (for example because of a malignant disease)
Beschrijving

ID.10

Datatype

boolean

Similar models

Eligibility Pulmonary Arterial Hypertension WHO Group I NCT02198456

Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
age >17
boolean
ID.2
Item
pulmonary arterial hypertension who group i who are going to start a therapy with prostanoid
boolean
ID.3
Item
written informed consent
boolean
ID.4
Item
prostanoid naive
boolean
ID.5
Item
no change of the pulmonary arterial hypertension therapy within 3 weeks of inclusion into the study
boolean
Item Group
C0680251 (UMLS CUI)
ID.6
Item
pregnancy and lactation period
boolean
ID.7
Item
women of childbearing potential who do not use an effective and secure method for birth control
boolean
ID.8
Item
severe chronic kidney insufficiency (glomerular filtration rate <30), which will remain for more than 3 months
boolean
ID.9
Item
liver insufficiency child c
boolean
ID.10
Item
life expectancy shorter than the course of the study (for example because of a malignant disease)
boolean

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial